CLPT

Clearpoint Neuro Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↓ 0/10
Clearpoint Neuro sales and earnings growth
CLPT Growth
Low
  • Revenue Y/Y↑ 17.36%
  • EPS Y/Y↓ -31.58%
  • FCF Y/Y↓ -127.46%
Clearpoint Neuro gross and profit margin trends
CLPT Profitability
Neutral
  • Gross margin ↑ 62.30%
  • EPS margin↓ -71.60%
  • ROIC 5Y↓ -84.82%
Clearpoint Neuro net debt vs free cash flow
CLPT Risk
Poor
  • Debt / Equity↑ 3.4
  • Debt / FCF↓ 1.0
  • Interest coverage↓ -6.7

Clearpoint Neuro stock volatility is higher than the overall market. We give it a Poor risk rating.

↗ More Medical Devices stocks